Correspondence 0001213900-24-002310 from Fresh2 Group Ltd (FRES) (CIK 0001786511)
Fresh2 Group Ltd (FRES) (CIK 0001786511)
Date: Jan. 9, 2024 · CIK: 0001786511 · Accession: 0001213900-24-002310
AI Filing Summary & Sentiment
File numbers found in text: 001-39137
Referenced dates: December 22, 2023
Show Raw Text
CORRESP
1
filename1.htm
January
9, 2024
Juan
Grana
Lauren
Nguyen
Division
of Corporation Finance
Office
of Industrial Applications and Services
U.S.
Securities and Exchange Commission
Washington,
D.C. 20549
Re: Fresh2
Group Limited
Form
20-F filed May 16, 2023
File
No. 001-39137
Dear
Ladies and Gentlemen:
We
are submitting this letter in response to your letter dated December 22, 2023 in which the staff of the Division of Corporation Finance
(the “Staff”) provided comments to the Form 20-F for the year ended December 31, 2022 filed by Fresh2 Group Limited (the
“Company”). We are contemporaneously filing Amendment No.1 the Form 20-F.
Set
forth below are our responses to the comments. For your convenience, the text of each of such comments are reproduced in italics before
our response.
Form
20-F for the Year Ended December 31, 2022
Introduction,
page iii
1. Provide
a clear description of how cash is transferred through your organization. We note your disclosure
on page 40 that you “make loans to [y]our PRC subsidiaries” or “may make additional
capital contributions to [y]our wholly foreign-owned subsidiaries in China.” We also
note your disclosure on page 43 that “Under [y]our current corporate structure, [y]our
holding company incorporated in the BVI primarily relies on dividend payments from [y]our
PRC subsidiaries to fund [y]our cash and financing requirements.” Please quantify any
cash flows and transfers of other assets by type that have occurred between you and your
subsidiaries, and the direction of transfer. Also quantify any dividends or distributions
that your subsidiaries have made to you and which entity made such transfer, and their tax
consequences. Your disclosure should make clear if no transfers, dividends, or distributions
have been made to date.
In
response to the Staff’s comment, we have provided the requested disclosure in the Introduction to the accompanying amendment to
our Form 20-F for the year Ended December 31, 2022 (the “Form 20-F”).
2. State
affirmatively whether you or your subsidiaries have received all requisite permissions or
approvals from the China Securities Regulatory Commission (CSRC), Cyberspace Administration
of China (CAC) or any other governmental agency that is required to approve your operations,
and whether any permissions or approvals have been denied.
In
response to the Staff’s comment, we have provided the requested disclosure in the Introduction to the accompanying amendment to
our Form 20-F.
Item
3.D. Risk Factors, page 1
3. Given
the Chinese government’s significant oversight and discretion over the conduct and
operations of your business, please revise your disclosure to highlight the risk that the
Chinese government may intervene or influence your operations at any time, which could result
in a material change in your operations and/or the value of your securities.
In
response to the Staff’s comment, we have revised the disclosure in Risk Factors in the accompanying amendment to our Form 20-F.
4. In
light of recent events indicating greater oversight by the Cyberspace Administration of China
(CAC) over data security, please revise your disclosure to explain to what extent you believe
that you are compliant with the regulations or policies that have been issued by the CAC
to date.
In
response to the Staff’s comment, we have revised the disclosure in Risk Factors in the accompanying amendment to our Form 20-F.
2
We
are subject to liability risks stemming from our foreign status, which could make it more difficult for investors to sue or enforce...,
page 54
5. We
note your disclosure that “certain of [y]our directors and executive officers reside
within China for a significant portion of a year or are PRC nationals and a substantial portion
of their assets are within China.” Please disclose which directors and executive officers
reside within China or are PRC nationals. To the extent that one or more of your officers
and/or directors are located in China or Hong Kong, please create a separate Enforceability
of Civil Liabilities section for the discussion of the enforcement risks related to civil
liabilities due to your officers and directors being located in China or Hong Kong. Please
disclose that it will be more difficult to enforce liabilities and enforce judgments on those
individuals. For example, revise to discuss more specifically the limitations on investors
being able to effect service of process and enforce civil liabilities in China, lack of reciprocity
and treaties, and cost and time constraints.
In
response to the Staff’s comment, we have provided the requested disclosure in this Risk Factor in the accompanying amendment to
our Form 20-F.
Item
16F. Change in Registrant’s Certifying Accountant, page 155
6. Please
provide all of the disclosures required by Item 16F of Form 20-F. Ensure that you file your
former accountant’s letter stating whether it agrees with the statements made by you
in Item 16F and, if not, stating the respects in which it does not agree. See Item 16F(a)(3)
of Form 20-F.
In
response to the Staff’s comment, we have provided the requested disclosure in Item 16F in the accompanying amendment to our Form
20-F and have included the former accountant’s letter as an exhibit.
Item
19. Exhibits, page 157
7. We
note the certifications provided in Exhibits 12.1 and 12.2 do not include paragraph
4(b) and the introductory language in paragraph 4 referring to internal control over financial reporting. Please amend the filing to
provide revised certifications that include the required information.
In
response to the Staff’s comment, we have provided the requested revised certifications.
3
If
you have any further questions, please do not hesitate to contact me at 917-397-6890 , or our counsel, Pang Zhang-Whittaker, at 212-238-8844.
Very
truly yours,
Fresh2
Group Limited
By:
/s/
Haohan Xu
Name:
Haohan Xu
Title:
Chief Executive Officer
4
Please
contact Jeanne Baker at 202-551-3691 or Terence O’Brien at 202-551-3355 if you have questions regarding comments on the financial statements
and related matters. Please contact Juan Grana at 202-551-6034 or Lauren Nguyen at 202-551-3642 with any other questions.
Sincerely,
Division
of Corporation Finance
Office of Industrial Applications and
Services
5